List of Centrexion Therapeutics patents

Patents where

Current Assignee

Name

Centrexion Therapeutics

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 11517546 High concentration local anesthetic formulations	Patent 11517546 was granted and assigned to Centrexion Therapeutics on December, 2022 by the United States Patent and Trademark Office.	Centrexion Therapeutics	Centrexion Therapeutics	United States Patent and Trademark Office	11517546	December 6, 2022
‌ US Patent 11000490 Stable aqueous capsaicin injectable formulations and medical uses thereof	Patent 11000490 was granted and assigned to Centrexion Therapeutics on May, 2021 by the United States Patent and Trademark Office.	Centrexion Therapeutics	Centrexion Therapeutics	United States Patent and Trademark Office	11000490	May 11, 2021
‌ US Patent 10493047 Stable aqueous capsaicin injectable formulations and medical uses thereof	Patent 10493047 was granted and assigned to Centrexion Therapeutics on December, 2019 by the United States Patent and Trademark Office.	Centrexion Therapeutics	Centrexion Therapeutics	United States Patent and Trademark Office	10493047	December 3, 2019
‌ US Patent 11344516 Stable aqueous capsaicin injectable formulations and medical uses thereof	Patent 11344516 was granted and assigned to Centrexion Therapeutics on May, 2022 by the United States Patent and Trademark Office.	Centrexion Therapeutics	Centrexion Therapeutics	United States Patent and Trademark Office	11344516	May 31, 2022
‌ US Patent 10568885 (4-((3R,4R)-3-methoxytetrahydro-pyran-4-ylamino)piperidin-1-y1)(5-methyl-6-(((2R,6S)-6-(p-tolyl)tetrahydro-2H-pyran-2-citrate	Patent 10568885 was granted and assigned to Centrexion Therapeutics on February, 2020 by the United States Patent and Trademark Office.	Centrexion Therapeutics	Centrexion Therapeutics	United States Patent and Trademark Office	10568885	February 25, 2020
‌ US Patent 10213428 (4-((3R,4R)-3-methoxytetrahydro-pyran-4-ylamino)piperidin-1-yl)(5-methyl-6-(((2R,6S)-6-(p-tolyl)tetrahydro-2H-pyran-2-yl)methylamino)pyrimidin-4-yl)methanone citrate	Patent 10213428 was granted and assigned to Centrexion Therapeutics on February, 2019 by the United States Patent and Trademark Office.	Centrexion Therapeutics	Centrexion Therapeutics	United States Patent and Trademark Office	10213428	February 26, 2019
‌ US Patent 9670222 CCR2 receptor antagonists and uses thereof	Patent 9670222 was granted and assigned to Centrexion Therapeutics on June, 2017 by the United States Patent and Trademark Office.		Centrexion Therapeutics	United States Patent and Trademark Office	9670222	June 6, 2017
‌ US Patent 11045459 Compositions and methods for intrathecal administration of MCOPPB for pain relief	Patent 11045459 was granted and assigned to Centrexion Therapeutics on June, 2021 by the United States Patent and Trademark Office.	Centrexion Therapeutics	Centrexion Therapeutics	United States Patent and Trademark Office	11045459	June 29, 2021
‌ US Patent 11447444 Capsaicinoid prodrug compounds and their use in treating medical conditions		Centrexion Therapeutics	Centrexion Therapeutics	United States Patent and Trademark Office	11447444	September 20, 2022
‌ US Patent 10196402 CCR2 receptor antagonists and uses thereof	Patent 10196402 was granted and assigned to Centrexion Therapeutics on February, 2019 by the United States Patent and Trademark Office.	Centrexion Therapeutics	Centrexion Therapeutics	United States Patent and Trademark Office	10196402	February 5, 2019
‌ US Patent 10166214 Somatostatin receptor subtype 4 (SSTR4) agonists	Patent 10166214 was granted and assigned to Centrexion Therapeutics on January, 2019 by the United States Patent and Trademark Office.	Centrexion Therapeutics	Centrexion Therapeutics	United States Patent and Trademark Office	10166214	January 1, 2019
‌ US Patent 9789082 Somatostatin receptor subtype 4 (SSTR4) agonists	Patent 9789082 was granted and assigned to Centrexion Therapeutics on October, 2017 by the United States Patent and Trademark Office.		Centrexion Therapeutics	United States Patent and Trademark Office	9789082	October 17, 2017
‌ US Patent 10112934 (Cyano-dimethyl-methyl)-isoxazoles and -[1,3,4]thiadiazoles	Patent 10112934 was granted and assigned to Centrexion Therapeutics on October, 2018 by the United States Patent and Trademark Office.	Centrexion Therapeutics	Centrexion Therapeutics	United States Patent and Trademark Office	10112934	October 30, 2018
‌ US Patent 10772853 Stable aqueous capsaicin injectable formulations and medical uses thereof	Patent 10772853 was granted and assigned to Centrexion Therapeutics on September, 2020 by the United States Patent and Trademark Office.	Centrexion Therapeutics	Centrexion Therapeutics	United States Patent and Trademark Office	10772853	September 15, 2020
‌ US Patent 10765649 Stable aqueous capsaicin injectable formulations and medical uses thereof	Patent 10765649 was granted and assigned to Centrexion Therapeutics on September, 2020 by the United States Patent and Trademark Office.	Centrexion Therapeutics	Centrexion Therapeutics	United States Patent and Trademark Office	10765649	September 8, 2020
‌ US Patent 11046706 CCR2 receptor antagonists and uses thereof	Patent 11046706 was granted and assigned to Centrexion Therapeutics on June, 2021 by the United States Patent and Trademark Office.	Centrexion Therapeutics	Centrexion Therapeutics	United States Patent and Trademark Office	11046706	June 29, 2021
‌ US Patent 11254659 Capsaicinoid prodrug compounds and their use in treating medical conditions	Patent 11254659 was granted and assigned to Centrexion Therapeutics on February, 2022 by the United States Patent and Trademark Office.	Centrexion Therapeutics	Centrexion Therapeutics	United States Patent and Trademark Office	11254659	February 22, 2022
‌ US Patent 11026903 Methods and compositions for treatment of pain using capsaicin	Patent 11026903 was granted and assigned to Centrexion Therapeutics on June, 2021 by the United States Patent and Trademark Office.	Centrexion Therapeutics	Centrexion Therapeutics	United States Patent and Trademark Office	11026903	June 8, 2021
‌ US Patent 10758502 High concentration local anesthetic formulations		Centrexion Therapeutics	Centrexion Therapeutics	United States Patent and Trademark Office	10758502	September 1, 2020
‌ US Patent 10675268 Somatostatin receptor subtype 4 (SSTR4) agonists	Patent 10675268 was granted and assigned to Centrexion Therapeutics on June, 2020 by the United States Patent and Trademark Office.	Centrexion Therapeutics	Centrexion Therapeutics	United States Patent and Trademark Office	10675268	June 9, 2020
‌ US Patent 10570125 (Cyano-dimethyl-methyl)-isoxazoles and -[1,3,4]thiadiazoles	Patent 10570125 was granted and assigned to Centrexion Therapeutics on February, 2020 by the United States Patent and Trademark Office.	Centrexion Therapeutics	Centrexion Therapeutics	United States Patent and Trademark Office	10570125	February 25, 2020
‌ US Patent 11992470 Stable aqueous capsaicin injectable formulations and medical uses thereof	Patent 11992470 was granted and assigned to Centrexion Therapeutics on May, 2024 by the United States Patent and Trademark Office.	Centrexion Therapeutics	Centrexion Therapeutics	United States Patent and Trademark Office	11992470	May 28, 2024
‌ US Patent 11872219 Compositions and methods for intrathecal administration of MCOPPB for pain relief	Patent 11872219 was granted and assigned to Centrexion Therapeutics on January, 2024 by the United States Patent and Trademark Office.	Centrexion Therapeutics	Centrexion Therapeutics	United States Patent and Trademark Office	11872219	January 16, 2024
‌ US Patent 12076321 (4-((3R,4R)-3-methoxytetrahydro-pyran-4-ylamino)piperidin-1-yl)(5-methyl-6-(((2R,6S)-6-(p-tolyl)tetrahydro-2H-pyran-2-yl)methylamino)pyrimidin-4-yl)methanone citrate	Patent 12076321 was granted and assigned to Centrexion Therapeutics on September, 2024 by the United States Patent and Trademark Office.	Centrexion Therapeutics	Centrexion Therapeutics	United States Patent and Trademark Office	12076321	September 3, 2024

24 results

0 selected

24 results

0 selected